AIM ImmunoTech - 53 Year Dividend History | AIM
Historical dividend payout and yield for AIM ImmunoTech (AIM) since 1971. The current TTM dividend payout for AIM ImmunoTech (AIM) as of April 25, 2024 is $0.00. The current dividend yield for AIM ImmunoTech as of April 25, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.022B |
$0.000B |
|
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
